Insider Confidence Amidst Volatility: Is Alignment Healthcare (NASDAQ: ALHC) Stock Undervalued?

• A key executive at Alignment Healthcare, Inc. (NASDAQ:ALHC) demonstrated confidence by purchasing 14,848 shares, despite a recent 31% stock price decline.
• The Alignment Healthcare stock is considered "technically oversold" and "modestly undervalued" by GuruFocus, with a current price of $15.35 against a GF Value estimate of $18.76.
• This individual insider buying contrasts with a broader trend of $29.40 million in insider selling over the last three months, presenting a mixed investment picture for Alignment Healthcare.

Alignment Healthcare, Inc. (NASDAQ:ALHC) is a health insurance company offering Medicare Advantage plans. The company focuses on a coordinated care model to improve health for its members. As detailed in its 2025 Impact Report, this strategy helps reduce emergency room visits and hospital stays compared to traditional Medicare fee-for-service benchmarks.

On June 2, 2026, a key executive showed confidence in Alignment Healthcare's future. Kent Mark D., the President - MSO, purchased 14,848 shares of Alignment Healthcare's common stock. The shares were bought at a price of $13.31 each. This transaction established his entire current holding in the company.

This insider purchase is notable given Alignment Healthcare's recent performance. Alignment Healthcare's stock price declined by 31% over the last four weeks. According to an analysis by Zacks Investment Research, this sharp drop has caused the stock to become "technically oversold." This term means the selling pressure may have been excessive, possibly indicating a potential price recovery for the ALHC stock.

However, this individual purchase contrasts with a wider trend. As highlighted by GuruFocus, company insiders sold $29.40 million worth of Alignment Healthcare stock in the last three months. Large amounts of insider selling can sometimes signal a lack of confidence from those with deep knowledge of the company, creating a mixed picture for investors.

Despite the recent price drop, some analyses suggest the ALHC stock may be undervalued. GuruFocus reports that Alignment Healthcare is considered "modestly undervalued" with a price of $15.35 on May 29, 2026, which is below its GF Value estimate of $18.76. The company also holds a strong GF Score of 86 out of 100, suggesting potential for higher long-term returns for Alignment Healthcare investors.